Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Eton, Fujifilm, Humacyte, Immunitybio, Jiangsu Hengrui, Johnson & Johnson, Norgine, Novaliq, Novartis, Zyversa.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fziomed, Insightec.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allurion, Astrazeneca, Denali, Kalvista, Lexeo, Mustang, Nurix.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biocon, Dizal, Hutchmed, Mesoblast, Takeda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Boston Scientific, Morphic Medical, Sirtex Medical, Thermo Fisher Scientific.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Apotex, Biocon, Dizal, Johnson & Johnson, OS Therapies, Regeneron.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Matortho.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Hikma, Mabxience, Merck.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fasikl, Intuitive, Life Molecular, Moon Surgical, Piur Imaging.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Camurus, Clene, Hemispherian, Jazz, Mesoblast, Vertex.